These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 32196108)
1. High-Dose Intravenous Immunoglobulin Is Effective Diabetic Polyneuropathy Resistant to Conventional Treatments. Results of a Double-Blind, Randomized, Placebo-Controlled Trial: Comments. Wee TC; Tan YL Pain Med; 2020 Oct; 21(10):2603-2604. PubMed ID: 32196108 [No Abstract] [Full Text] [Related]
2. High-Dose Intravenous Immunoglobulin Is Effective in Painful Diabetic Polyneuropathy Resistant to Conventional Treatments. Results of a Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial. Jann S; Fazio R; Cocito D; Toscano A; Schenone A; Marfia GA; Antonini G; De Toni Franceschini L; Mazzeo A; Grandis M; Velardo D; Mataluni G; Peci E Pain Med; 2020 Mar; 21(3):576-585. PubMed ID: 31904855 [TBL] [Abstract][Full Text] [Related]
3. Treatment with benfotiamine in patients with diabetic sensorimotor polyneuropathy: A double-blind, randomized, placebo-controlled, parallel group pilot study over 12 months. Stirban OA; Zeller-Stefan H; Schumacher J; Gaus W; Ziegler D; Schuerholz T; Pop-Busui R J Diabetes Complications; 2020 Dec; 34(12):107757. PubMed ID: 33069584 [No Abstract] [Full Text] [Related]
4. Intravenous immunoglobulin G is remarkably beneficial in chronic immune dysschwannian/dysneuronal polyneuropathy, diabetes-2 neuropathy, and potentially in severe acute respiratory syndrome. Engel WK Acta Myol; 2003 Dec; 22(3):97-103. PubMed ID: 15088499 [TBL] [Abstract][Full Text] [Related]
5. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. Ziegler D; Hanefeld M; Ruhnau KJ; Hasche H; Lobisch M; Schütte K; Kerum G; Malessa R Diabetes Care; 1999 Aug; 22(8):1296-301. PubMed ID: 10480774 [TBL] [Abstract][Full Text] [Related]
7. Intravenous immunoglobulin therapy for small fiber neuropathy: study protocol for a randomized controlled trial. de Greef BT; Geerts M; Hoeijmakers JG; Faber CG; Merkies IS Trials; 2016 Jul; 17(1):330. PubMed ID: 27439408 [TBL] [Abstract][Full Text] [Related]
8. Polyneuropathy in type 2 diabetes mellitus. Engel WK Lancet; 2001 Dec; 358(9298):2086. PubMed ID: 11755652 [No Abstract] [Full Text] [Related]
9. Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial. Schwartz S; Etropolski M; Shapiro DY; Okamoto A; Lange R; Haeussler J; Rauschkolb C Curr Med Res Opin; 2011 Jan; 27(1):151-62. PubMed ID: 21162697 [TBL] [Abstract][Full Text] [Related]
10. Beneficial effects of nano-curcumin supplement on depression and anxiety in diabetic patients with peripheral neuropathy: A randomized, double-blind, placebo-controlled clinical trial. Asadi S; Gholami MS; Siassi F; Qorbani M; Sotoudeh G Phytother Res; 2020 Apr; 34(4):896-903. PubMed ID: 31788880 [TBL] [Abstract][Full Text] [Related]
11. A comparison a amitriptyline and maprotiline in the treatment of painful polyneuropathy in diabetics and nondiabetics. Vrethem M; Boivie J; Arnqvist H; Holmgren H; Lindström T; Thorell LH Clin J Pain; 1997 Dec; 13(4):313-23. PubMed ID: 9430812 [TBL] [Abstract][Full Text] [Related]
12. Bilateral phrenic neuropathies in a diabetic patient responsive to intravenous immunoglobulin: a case report. Rison RA; Beydoun SR Clin Neurol Neurosurg; 2011 Nov; 113(9):788-91. PubMed ID: 21906870 [TBL] [Abstract][Full Text] [Related]
13. Benfotiamine in the treatment of diabetic polyneuropathy--a three-week randomized, controlled pilot study (BEDIP study). Haupt E; Ledermann H; Köpcke W Int J Clin Pharmacol Ther; 2005 Feb; 43(2):71-7. PubMed ID: 15726875 [TBL] [Abstract][Full Text] [Related]
14. The effect of ubiquinone in diabetic polyneuropathy: a randomized double-blind placebo-controlled study. Hernández-Ojeda J; Cardona-Muñoz EG; Román-Pintos LM; Troyo-Sanromán R; Ortiz-Lazareno PC; Cárdenas-Meza MA; Pascoe-González S; Miranda-Díaz AG J Diabetes Complications; 2012; 26(4):352-8. PubMed ID: 22595020 [TBL] [Abstract][Full Text] [Related]